注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Morphic Holding Inc是一家生物製藥公司。該公司致力於發現和開髮用於治療嚴重慢性疾病的口服小分子整合素療法,包括自身免疫、心血管和代謝疾病、纖維化和癌症。該公司的Morphic整合素技術平台(MInT平台)有助於開發新的候選產品,旨在實現口服給藥所需的效力、高選擇性和藥物特性。該公司正在推進其管道,包括其主要候選產品MORF-057,這是一種影響炎症的α4β7特異性整合素抑製劑,用於治療炎症性腸病(IBD)的臨床開發。其還開發了選擇性口服αvβ6特異性整合素抑製劑,用於治療纖維化疾病,包括特發性肺纖維化。其子公司Morphic Therapeutic, Inc.是一家生物製藥公司。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Gustav A. Christensen | 73 | 2016 | Independent Chairman |
Yury V. Popov | - | - | Member of Scientific Advisory Board |
Scott L. Friedman | - | - | Member of Scientific Advisory Board |
Susannah Gray | 61 | 2021 | Independent Director |
Norbert W. Bischofberger | 66 | 2019 | Independent Director |
Martin William Edwards | 66 | 2020 | Independent Director |
Amir H. Nashat | 50 | 2017 | Independent Director |
Albert J. Robichaud | 62 | - | Member of Scientific Advisory Board |
Ulrich H. von Andrian-Werburg | - | - | Member of Scientific Advisory Board |
Shelia M. Violette | - | - | Member of Scientific Advisory Board |
Joseph P. Slattery | 58 | 2019 | Independent Director |
Brian G. Feagan | - | - | Member of Clinical Advisory Board |
Nisha Nanda | 48 | 2021 | Independent Director |
Silvio Danese | - | - | Member of Clinical Advisory Board |
Laurent Peyrin-Biroulet | - | - | Member of Clinical Advisory Board |
Bruce E. Sands | - | - | Member of Clinical Advisory Board |
Stefan Schreiber | 61 | 2023 | Member of Clinical Advisory Board |
Praveen P. Tipirneni | 56 | 2015 | CEO, MD & Director |
Timothy A. Springer | 76 | 2014 | Founder, Independent Director & Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核